-

KBRA Releases Monthly CMBS Trend Watch

NEW YORK--(BUSINESS WIRE)--KBRA releases the December 2022 issue of CMBS Trend Watch.

U.S. CMBS private label issuance began to slow in second-quarter 2022 following a strong start to the year, owing to higher interest rates and uncertainty regarding future Federal Reserve actions. When the dust settled on full-year (FY) 2022, private label issuance totaled $70.2 billion, down 36.5% year-over-year. Based on current visibility, there could be up to seven deals that launch in January 2023, including as many as three conduits, two single-borrower (SB) transactions, one commercial real estate collateralized loan obligation (CRE CLO) transaction, and one Freddie Mac K-Series.

December’s surveillance activity included rating actions on 529 classes consisting of 499 affirmations, 22 downgrades, two upgrades, and six Watch Developing placements. The activity was effectuated across 45 transactions including 32 conduits, 10 SB transactions, two CRE CLO transactions, and one large loan (LL) transaction. In December, one KBRA-rated CRE CLO transaction that was launched in November was closed.

The Spotlight section reviews the rating transitions that occurred in 2022. CMBS ratings were largely stable in 2022 as 96% of the outstanding conduit, LL, and SB ratings were affirmed over the year. The majority of rating changes were downgrades (204), which came in well under the 371 and 292 from the prior two years, respectively. There were 10 upgrades, which is relatively in line with 2021 (11) and 2020 (eight).

Click here to view the report.

Related Publications

About KBRA

KBRA is a full-service credit rating agency registered in the U.S., the EU, and the UK, and is designated to provide structured finance ratings in Canada. KBRA’s ratings can be used by investors for regulatory capital purposes in multiple jurisdictions.

Contacts

Cammy Wan, Analyst, CMBS Ratings Surveillance
+1 (646) 731-3327
cammy.wan@kbra.com

Larry Kay, Senior Director, CMBS Ratings Surveillance
+1 (646) 731-2452
larry.kay@kbra.com

Roy Chun, Senior Managing Director, CMBS Ratings Surveillance
+1 (646) 731-2376
roy.chun@kbra.com

Eric Thompson, Senior Managing Director, Head of Global Structured Finance Ratings
+1 (646) 731-2355
eric.thompson@kbra.com

Business Development Contact

Michele Patterson, Managing Director
+1 (646) 731-2397
michele.patterson@kbra.com

KBRA

Details
Headquarters: New York City, New York
CEO: Jim Nadler
Employees: 400+
Organization: PRI

Release Versions

Contacts

Cammy Wan, Analyst, CMBS Ratings Surveillance
+1 (646) 731-3327
cammy.wan@kbra.com

Larry Kay, Senior Director, CMBS Ratings Surveillance
+1 (646) 731-2452
larry.kay@kbra.com

Roy Chun, Senior Managing Director, CMBS Ratings Surveillance
+1 (646) 731-2376
roy.chun@kbra.com

Eric Thompson, Senior Managing Director, Head of Global Structured Finance Ratings
+1 (646) 731-2355
eric.thompson@kbra.com

Business Development Contact

Michele Patterson, Managing Director
+1 (646) 731-2397
michele.patterson@kbra.com

More News From KBRA

KBRA Assigns Preliminary Ratings to Research-Driven Pagaya Motor Asset Trust 2026-R1 and Research-Driven Pagaya Motor Trust 2026-R1

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to six classes of notes issued by Research-Driven Pagaya Motor Asset Trust 2026-R1 and Research-Driven Pagaya Motor Trust 2026-R1 (collectively “RPM 2026-R1”), an auto loan ABS transaction. RPM 2026-R1 has initial credit enhancement levels of 35.69% for the Class A notes to 2.65% for the Class E-2 notes. Credit enhancement is comprised of overcollateralization, subordination of junior note classes (except for the Class E-2 notes), a ca...

KBRA Releases Research – What’s up, Doc – Medical Professional Mortgages, A New Niche in RMBS?

NEW YORK--(BUSINESS WIRE)--KBRA releases research assessing the characteristics of medical professional mortgage (MPM) loans, with a focus on their potential role as a niche collateral segment within the prime private label residential mortgage-backed securities (RMBS) market. MPMs, often called physician or doctor loans, are specialized prime mortgage programs designed for medical professionals whose early-career financial profiles often include high student debt, limited savings, and reliance...

KBRA Assigns Preliminary Ratings to OBX 2026-NQM4 Trust

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 14 classes of mortgage-backed notes from OBX 2026-NQM4 Trust, a $789.6 million non-prime RMBS transaction. The underlying collateral, comprising 1,476 residential mortgages, is characterized by fixed-rate mortgages (FRMs) and hybrid adjustable-rate mortgages (ARMs) making up 92.3% and 7.7% of the pool, respectively. A majority of the loans are either classified as non-qualified mortgages (Non-QM; 37.0%) or exempt (51.6%) from the Ab...
Back to Newsroom